RAPT Therapeutics's total assets for Q4 2024 were $240.32M, an increase of 121.57% from the previous quarter. RAPT total liabilities were $50.42M for the fiscal quarter, a 289.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.